Cargando…
Retracted: Cell Division Cycle-Associated Protein 3 (CDCA3) Is a Potential Biomarker for Clinical Prognosis and Immunotherapy in Pan-Cancer
Autor principal: | International, BioMed Research |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10307199/ https://www.ncbi.nlm.nih.gov/pubmed/37388379 http://dx.doi.org/10.1155/2023/9870382 |
Ejemplares similares
-
Retracted: The Value of m5C-Related lncRNAs in the Prognostic Assessment and Immunotherapy of Stomach Adenocarcinoma
por: International, BioMed Research
Publicado: (2023) -
Retracted: Influence of Nutritional Support Program on Gastrointestinal Function, Complication Rate, and Prognosis in Elderly Sufferers with CI
por: International, BioMed Research
Publicado: (2023) -
Retracted: Investigation of the Disparities in Ultrasound Imaging Features of miR-323, miR-409-3p, and VEGF Expression Scales in Different Clinicopathological Features of Prostate Carcinoma and Their Correlation with Prognosis
por: International, BioMed Research
Publicado: (2023) -
Retracted: Dental 3D Printing Design Based on Neurodegeneration and Virtual Reality Imaging Technology
por: International, BioMed Research
Publicado: (2023) -
Retracted: Abnormal COX2 Protein Expression May Be Correlated with Poor Prognosis in Oral Cancer: A Meta-Analysis
por: International, BioMed Research
Publicado: (2021)